ARMK · Aramark
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Oct 2, 2023; bars on opposite sides are not compared.
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Earnings Per Share non-GAAP | $1.52 | Nine Months Ended July 3, 2026 | — |
| Adjusted Net Income non-GAAP | $406.53M | Nine Months Ended July 3, 2026 | — |
| Adjusted Operating Income non-GAAP | $781.51M | Nine Months Ended July 3, 2026 | — |
| Adjusted Operating Income Growth (Constant Currency) non-GAAP | 11.7% | Nine Months Ended July 3, 2026 | — |
| Adjusted Operating Income Margin non-GAAP | 5.3% | Nine Months Ended July 3, 2026 | — |
| Adjusted Revenue (Organic) non-GAAP | $14.61B | Nine Months Ended July 3, 2026 | — |
| Adjusted Revenue Growth (Organic) non-GAAP | 8.6% | Nine Months Ended July 3, 2026 | — |
| Covenant Adjusted EBITDA non-GAAP | $1.62B | Twelve Months Ended July 3, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net Income Attributable to Aramark Stockholders (as reported) 382.91M
+334.03M Interest Expense, net
+133.49M Provision for Income Taxes
+518.5M Depreciation and Amortization
+67.41M Share-based compensation expense
+25.52M Unusual or non-recurring losses and (gains)
+42.05M Pro forma EBITDA for certain transactions
+117.65M Other
= Covenant Adjusted EBITDA 1.62B
|
|||
| Free Cash Flow non-GAAP | -$588.14M | Nine Months Ended July 3, 2026 | — |
| Net Debt non-GAAP | $5.63B | Twelve Months Ended July 3, 2026 | — |
| Net Debt/Covenant Adjusted EBITDA non-GAAP | 3.5 | Twelve Months Ended July 3, 2026 | — |
| Client retention rate | 98% | fiscal year to date | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ARMK
this stock
Aramark
|
$15.95B | +64.1% | +6.4% | 42.3 | 3.6% |
|
CTAS
Cintas Corp
|
$81.38B | +8.0% | +6.4% | — | 2.8% |
|
RELX
Relx PLC
|
$60.46B | -14.6% | — | — | 0.2% |
|
TRI
Thomson Reuters Corp /Can/
|
$43.71B | -20.4% | — | — | 3.1% |
|
CPRT
Copart Inc
|
$30.93B | -13.5% | +24.7% | 20.9 | 4.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Oct 2, 2023; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ARMK | +0.1% | +7.8% | +47.6% | +6.2% | +64.1% |
| SPY | -0.4% | +2.6% | +10.7% | +2.7% | +12.5% |
| vs SPY | +0.5% | +5.3% | +36.9% | +3.5% | +51.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.